Login / Signup

Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.

Daniel J LewisY H KimMadeleine Duvic
Published in: The British journal of dermatology (2018)
Keyphrases
  • hodgkin lymphoma
  • nk cells